2020
DOI: 10.1590/2175-8239-jbn-2019-0077
|View full text |Cite
|
Sign up to set email alerts
|

A rare case of PLA2R- and THSD7A-positive idiopathic membranous nephropathy

Abstract: Idiopathic membranous nephropathy (IMN) is a frequent cause of nephrotic syndrome in adults. In terms of etiology, the condition may be categorized as primary/idiopathic or secondary. Literature on the pathophysiology of IMN has indicated the presence of autoantibodies (PLA2R and THSD7A) directed against podocyte antigens. The detection of antibodies against a domain favors IMN. The presence of autoantibodies against one of the domains would in theory exclude the possibility of there being autoantibodies again… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 16 publications
1
4
0
Order By: Relevance
“…The immunohistochemical PLA2R1 positivity was not expected. These histological findings support that PLA2R1 positivity alone is specific for primary MN, as it is also observed, besides syphilis, in chronic Schistosoma mansoni [ 2 ] infection, membranous lupus nephritis [ 3 ] and cancer [ 4 ]. In this regard, PLA2R1 expression can be increased in podocytes by non-specific inflammatory mediators such as tumour necrosis factor-like weak inducer of apoptosis (TWEAK) [ 5 ].…”
supporting
confidence: 67%
“…The immunohistochemical PLA2R1 positivity was not expected. These histological findings support that PLA2R1 positivity alone is specific for primary MN, as it is also observed, besides syphilis, in chronic Schistosoma mansoni [ 2 ] infection, membranous lupus nephritis [ 3 ] and cancer [ 4 ]. In this regard, PLA2R1 expression can be increased in podocytes by non-specific inflammatory mediators such as tumour necrosis factor-like weak inducer of apoptosis (TWEAK) [ 5 ].…”
supporting
confidence: 67%
“…The reported frequencies of occurrence of anti-PLA2R and anti-THSD7A antibodies in MN are 50–80% and 5–10% ( 13 ), respectively; the target antigen of MN is uncertain in 10–20% of cases. The presence of one type of antibody does not exclude the presence of other antibody types, as shown by a reported case of anti-PLA2R- and anti-THSD7A-positive MN ( 34 ). It has been suggested that MGN is secondary to an increase in serum IgG4 concentration, which may be due to the deposition of the circulating immune complexes or other unknown mechanisms.…”
Section: Discussionmentioning
confidence: 95%
“…We conducted a systematic review of the literature on previous studies involving double antigen-positive IMN. By June 6, 2023, a total of 11 studies (7,(11)(12)(13)(14)(15)(16)(17)(18)(19)(20) involving 43 dual antigen-positive IMN patients, were included (Supplementary Table 1, Supplementary Figure 2). Of the 43 patients, highly detailed information was available for only 11, and we extracted clinical, pathological, and prognostic information for these 11 patients (Table 2) and then performed comparisons with the 6 dual antigen-positive IMN patients at our center (Supplementary Table 2).…”
Section: Literature Review and Information Extraction Of Previous Rep...mentioning
confidence: 99%
“…Indeed, many IMN target antigens have been discovered over the past decade, including thrombospondin type 1 domain containing 7A (THSD7A) and neuroepidermal growth factor-like type 1 protein (NELL-1) (4,5). However, the vast majority of IMN patients reported thus far are single antigenpositive; in contrast, dual antigen-positive IMN patients are very rare, with only a few such cases being briefly described in various studies (6)(7)(8). There is no specific study on the clinicopathological and prognostic characteristics of dual antigen-positive IMN patients, and the disease characteristics of such patients remain unclear.…”
Section: Introductionmentioning
confidence: 99%